Found 15 matching trials
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer PHASE2 Research purposes: the research design in the late more than 2 lines TNBC p...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer PHASE1 This study was designed to explore the clinical efficacy of Anlotinib combi...
Show More Location
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer PHASE4 This is a retrospective and prospective real-world clinical study of molecu...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma PHASE2 Soft tissue sarcoma is a rare cancer that often requires surgery combined w...
Show More Location
Cancer Hospital, National Cancer Center, CAMS & PUMC
Learn More & Join Trial
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ยฑ Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. PHASE2 This clinical study plans to enroll 69 endometrial cancer patients and 5-10...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer PHASE1 The purpose of the study is to evaluate the Efficacy and safety of Anti-PD-...
Show More Location
Sun Yat-sen University Cancer Centre
Learn More & Join Trial
Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma. PHASE1 To explore and evaluate the dose-limiting toxicity (DLT) profile of the fix...
Show More Location
Multiple Locations
Learn More & Join Trial
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer PHASE2 Brief Summary:
This study is for patients with advanced biliary tract canc...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes PHASE1 Abstract Study title: Single-center, Multi-cohort Exploratory Phase Ib/II C...
Show More Location
Multiple Locations
Learn More & Join Trial